First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF

Through a unique collaboration with FDA under the EAP, the BeAT-HF trial design allows for the possibility of approval of BAT, initially for symptom relief and subsequently for outcomes improvement.